176 related articles for article (PubMed ID: 15487693)
1. Light panretinal photocoagulation (LPRP) versus classic panretinal photocoagulation (CPRP) in proliferative diabetic retinopathy.
Bandello F; Brancato R; Menchini U; Virgili G; Lanzetta P; Ferrari E; Incorvaia C
Semin Ophthalmol; 2001 Mar; 16(1):12-8. PubMed ID: 15487693
[TBL] [Abstract][Full Text] [Related]
2. Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.
; Gross JG; Glassman AR; Jampol LM; Inusah S; Aiello LP; Antoszyk AN; Baker CW; Berger BB; Bressler NM; Browning D; Elman MJ; Ferris FL; Friedman SM; Marcus DM; Melia M; Stockdale CR; Sun JK; Beck RW
JAMA; 2015 Nov; 314(20):2137-2146. PubMed ID: 26565927
[TBL] [Abstract][Full Text] [Related]
3. Extended targeted retinal photocoagulation versus conventional pan-retinal photocoagulation for proliferative diabetic retinopathy in a randomized clinical trial.
Nikkhah H; Ghazi H; Razzaghi MR; Karimi S; Ramezani A; Soheilian M
Int Ophthalmol; 2018 Feb; 38(1):313-321. PubMed ID: 28168567
[TBL] [Abstract][Full Text] [Related]
4. Posterior sub-Tenon's capsule injection of triamcinolone acetonide prevents panretinal photocoagulation-induced visual dysfunction in patients with severe diabetic retinopathy and good vision.
Shimura M; Yasuda K; Shiono T
Ophthalmology; 2006 Mar; 113(3):381-7. PubMed ID: 16458970
[TBL] [Abstract][Full Text] [Related]
5. Red krypton and blue-green argon panretinal laser photocoagulation for proliferative diabetic retinopathy: a laboratory and clinical comparison.
Blankenship GW
Trans Am Ophthalmol Soc; 1986; 84():967-1003. PubMed ID: 2438841
[TBL] [Abstract][Full Text] [Related]
6. Visual dysfunction after panretinal photocoagulation in patients with severe diabetic retinopathy and good vision.
Shimura M; Yasuda K; Nakazawa T; Tamai M
Am J Ophthalmol; 2005 Jul; 140(1):8-15. PubMed ID: 15939392
[TBL] [Abstract][Full Text] [Related]
7. Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early Treatment Diabetic Retinopathy Study Research Group.
Ophthalmology; 1991 May; 98(5 Suppl):766-85. PubMed ID: 2062512
[TBL] [Abstract][Full Text] [Related]
8. Single-session vs multiple-session pattern scanning laser panretinal photocoagulation in proliferative diabetic retinopathy: The Manchester Pascal Study.
Muqit MM; Marcellino GR; Henson DB; Young LB; Patton N; Charles SJ; Turner GS; Stanga PE
Arch Ophthalmol; 2010 May; 128(5):525-33. PubMed ID: 20457972
[TBL] [Abstract][Full Text] [Related]
9. Central retinal thickness following panretinal photocoagulation using a multispot semi-automated pattern-scanning laser to treat ischaemic diabetic retinopathy: Treatment in one session compared with four monthly sessions.
Gabrielle PH; Massin P; Kodjikian L; Erginay A; Pallot C; Jonval L; Soudry A; Couturier A; Vardanian-Vartin C; Bron AM; Creuzot-Garcher C
Acta Ophthalmol; 2019 Aug; 97(5):e680-e687. PubMed ID: 30561087
[TBL] [Abstract][Full Text] [Related]
10. Reduction of severe macular edema in eyes with poor vision after panretinal photocoagulation for proliferative diabetic retinopathy.
Gardner TW; Eller AW; Friberg TR
Graefes Arch Clin Exp Ophthalmol; 1991; 229(4):323-8. PubMed ID: 1916318
[TBL] [Abstract][Full Text] [Related]
11. A clinical comparison of central and peripheral argon laser panretinal photocoagulation for proliferative diabetic retinopathy.
Blankenship GW
Ophthalmology; 1988 Feb; 95(2):170-7. PubMed ID: 2459641
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal triamcinolone as an adjunct to standard laser therapy in coexisting high-risk proliferative diabetic retinopathy and clinically significant macular edema.
Mirshahi A; Shenazandi H; Lashay A; Faghihi H; Alimahmoudi A; Dianat S
Retina; 2010 Feb; 30(2):254-9. PubMed ID: 20057344
[TBL] [Abstract][Full Text] [Related]
13. Panretinal photocoagulation combined with intravitreal bevacizumab in high-risk proliferative diabetic retinopathy.
Cho WB; Oh SB; Moon JW; Kim HC
Retina; 2009 Apr; 29(4):516-22. PubMed ID: 19262436
[TBL] [Abstract][Full Text] [Related]
14. Comparing two techniques of panretinal photocoagulation on visual acuity on patients with proliferative diabetic retinopathy.
Kovacic Z; Ivanisevic M; Bojic L; Hrgovic Z; Lesin M; Kurelovic D
Med Arch; 2012; 66(5):321-3. PubMed ID: 23097970
[TBL] [Abstract][Full Text] [Related]
15. [Panretinal photocoagulation with or without focal photocoagulation--the effect on central retinal thickness].
Danielescu C; Chiseliţă D
Oftalmologia; 2010; 54(2):99-103. PubMed ID: 20827919
[TBL] [Abstract][Full Text] [Related]
16. Randomized clinical trial to evaluate the effects of Pascal panretinal photocoagulation on macular nerve fiber layer: Manchester Pascal Study report 3.
Muqit MM; Marcellino GR; Henson DB; Fenerty CH; Stanga PE
Retina; 2011 Sep; 31(8):1699-707. PubMed ID: 21478808
[TBL] [Abstract][Full Text] [Related]
17. The effect of short versus long exposure times of argon laser panretinal photocoagulation on proliferative diabetic retinopathy.
Wade EC; Blankenship GW
Graefes Arch Clin Exp Ophthalmol; 1990; 228(3):226-31. PubMed ID: 2193849
[TBL] [Abstract][Full Text] [Related]
18. The effect of photocoagulation on visual acuity in diabetic patients suffering from diabetic macular edema and diabetic retinopathy.
Ilavska M
Bratisl Lek Listy; 2009; 110(7):419-22. PubMed ID: 19711829
[TBL] [Abstract][Full Text] [Related]
19. Long-term visual outcome in proliferative diabetic retinopathy patients after panretinal photocoagulation.
Dogru M; Nakamura M; Inoue M; Yamamoto M
Jpn J Ophthalmol; 1999; 43(3):217-24. PubMed ID: 10413257
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal bevacizumab (Avastin) prevention of panretinal photocoagulation-induced complications in patients with severe proliferative diabetic retinopathy.
Mason JO; Yunker JJ; Vail R; McGwin G
Retina; 2008 Oct; 28(9):1319-24. PubMed ID: 18667958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
